Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

0.4530
+0.01092.47%
Volume:242.66K
Turnover:108.22K
Market Cap:7.37M
PE:-0.90
High:0.4565
Open:0.4475
Low:0.4303
Close:0.4421
52wk High:1.13
52wk Low:0.2210
Shares:16.27M
Float Shares:15.83M
Volume Ratio:0.68
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5044
EPS(LYR):-0.5044
ROE:-74.56%
ROA:-35.63%
PB:1.17
PE(LYR):-0.90

Loading ...

Silo Pharma Inc - FDA Grants Ind Clearance to Demerx NB for Noribogaine Targeting Alcohol Use Disorder

THOMSON REUTERS
·
Apr 29

Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

GlobeNewswire
·
Apr 29

Silo Pharma expands into AI technology with Qwikagents asset purchase

TIPRANKS
·
Apr 23

Silo Pharma buys Qwikagents.ai platform assets, expands into AI agent market

Reuters
·
Apr 23

Rma Inc - to Submit Spc-15’S Ind to FDA and Launch Our First-in-Human Trial After FDA Approval

THOMSON REUTERS
·
Apr 23

Silo Pharma Announces Strategic Business Expansion Into Multi-Billion Dollar AI Agent Market With Acquisition of Managed AI Agent Platform, Qwikagents

THOMSON REUTERS
·
Apr 23

Silo Pharma highlights SPC-15 PTSD program after Trump order on psychedelic research

Reuters
·
Apr 20

Silo Pharma Receives European Patent Allowance for Licensed Novel Ptsd Prevention Therapy

THOMSON REUTERS
·
Apr 07

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

TIPRANKS
·
Apr 07

Silo Pharma says EPO signals intent to grant PTSD prevention therapy patent claims

Reuters
·
Apr 07

Silo Pharma issues 2.1 million shares in unregistered sale for QwikAgents assets

Reuters
·
Apr 03

Silo Pharma FY2025 operating loss narrows 9% to $(4.28) million; net loss drops 3.8% to $(4.23) million

Reuters
·
Mar 28

BRIEF-Silo Pharma Announces Share Buyback Program

Reuters
·
Feb 24

Silo Pharma announces $1M share repurchase program

TIPRANKS
·
Feb 24

Silo Pharma Inc - Announces $1 Mln Share Repurchase Program

THOMSON REUTERS
·
Feb 24

Silo Pharma Receives Notice of Allowance in Japan for Spc-15, Expanding Global Intellectual Property Portfolio

THOMSON REUTERS
·
Feb 18

Silo Pharma Receives Japan Notice of Allowance for SPC-15 PTSD Intranasal Therapy Patent Application

Reuters
·
Feb 18

Silo Pharma Signs LOI with Allucent for Phase 1 SPC-15 Clinical Trials

Reuters
·
Dec 30, 2025

Silo Pharma Executes Letter of Intent With Allucent to Support Phase 1 Clinical Development of Spc-15

THOMSON REUTERS
·
Dec 30, 2025

Silo Pharma Faces Potential Nasdaq Delisting Over Minimum Bid Price Compliance

Reuters
·
Dec 29, 2025